Strength | Level 0 | Level I | Level II | Level III | Level IV | Level V |
Before treatment in group A | 14 | 11 | 12 | 10 | 3 | 0 |
After treatment in group A | 2 | 6 | 10 | 15 | 13 | 4 |
Comparison of before and after treatment in group A (X2) | 10.71 | 1.77 | 0.23 | 1.33 | 7.44 | 2.34 |
P value | <0.01 | >0.05 | >0.05 | >0.05 | <0.01 | >0.05 |
Before treatment in group B | 14 | 10 | 12 | 11 | 3 | 0 |
After treatment in group B | 1 | 4 | 7 | 15 | 17 | 6 |
Comparison of before and after treatment in group B (X2) | 13.25 | 2.99 | 1.62 | 0.83 | 12.25 | 4.43 |
P value | <0.01 | >0.05 | >0.05 | >0.05 | <0.01 | <0.05 |
Before treatment in group C | 14 | 11 | 12 | 10 | 3 | 0 |
After treatment in group C | 0 | 2 | 6 | 13 | 18 | 11 |
Comparison of before and after treatment in group C (X2) | 16.28 | 7.16 | 2.44 | 0.51 | 13.56 | 12.36 |
P value | <0.01 | <0.01 | >0.05 | >0.05 | <0.01 | <0.01 |
Comparison of group A with B after treatment (X2) | 0.00 | 0.44 | 0.64 | 0.00 | 0.76 | 0.44 |
P value | >0.05 | >0.05 | >0.05 | >0.05 | >0.05 | >0.05 |
Comparison of group A with C after treatment (X2) | ― | 1.22 | 1.19 | 0.2 | 1.17 | 3.84 |
P value | ― | >0.05 | <0.01 | >0.05 | >0.05 | 0.05 |
Comparison of group B with C after treatment (X2) | ― | 0.18 | 0.09 | 0.20 | 0.04 | 1.77 |
P value | ― | >0.05 | >0.05 | >0.05 | >0.05 | >0.05 |